ITF Therapeutics LLC, the U.S. affiliate of Italfarmaco, today announced that results on givinostat for the treatment of Duchenne muscular dystrophy (DMD) are being presented at the 2025 Neuromuscular ...
BioPorto Sponsors Conferences on Pediatric Critical Care with New NGAL Scientific Data Presented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback